News
Australian study finds no adverse impact of repeated Covid vaccinations on metabolism, inflammation, or cardiovascular ...
1d
GlobalData on MSNAstraZeneca’s Truqap fails in another Phase III trialThe FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.
AstraZeneca has warned that countries must buy more of its cutting-edge medicines or jobs and investment will shift abroad.
Docquity, Southeast Asia's largest community of healthcare professionals (HCPs), and global biopharmaceutical leader ...
1d
The Print on MSNPune-based firm receives major international grant to accelerate development of Nipah virus vaccineGennova has been working on self-amplifying mRNA vaccine. mRNA vaccines use body’s machinery to make antigenic protein rather ...
The U.S. Food and Drug Administration (FDA) is planning to require all new vaccines to undergo placebo-controlled trials ...
The Trump administration is investing $500M in a project to develop "universal" vaccines that protect against multiple virus ...
Vaccine Nation is a warning about the acceleration of the anti-vaccination movement during the pandemic and worrying declines ...
Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...
Investor AB maintains low leverage, with a net debt of ~SEK 9.5 billion and a conservative long-term approach. Read why I ...
Dr. Ali Sherif normally gives about 50 doses of the measles vaccine to children each month at his clinic in Hobbs, New Mexico ...
2d
Pharmaceutical Technology on MSNAstraZeneca CEO calls for increased European investment in pharmaCEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results